Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Brazil
/
Healthcare
/
Oncoclínicas do Brasil Serviços Médicos
ONCO3
Oncoclínicas do Brasil Serviços Médicos
Brazil's Tightening Policies And High Costs Will Erode Margins
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 8 Analysts
Published
21 Jul 25
Updated
21 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
R$2.00
50.0% overvalued
intrinsic discount
21 Aug
R$3.00
1Y
-54.3%
7D
-39.8%
Loading
1Y
-54.3%
7D
-39.8%
Author's Valuation
R$2.0
50.0% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
R$2.0
50.0% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-947m
7b
2014
2017
2020
2023
2025
2026
2028
Revenue R$7.0b
Earnings R$565.1m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
8.15%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
21.30%
Calculation
R$565.06m
Earnings '28
x
3.89x
PE Ratio '28
=
R$2.20b
Market Cap '28
R$2.20b
Market Cap '28
/
632.79m
No. shares '28
=
R$3.48
Share Price '28
R$3.48
Share Price '28
Discounted to 2025 @ 19.43% p.a.
=
R$2.04
Fair Value '25
